Evidence map›Paper›PMID 38604632›Full record

ArticleBMJ open2024

Further development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ).

Polly Duncan, Lauren J Scott, Shoba Dawson, Muzrif Munas, Yvette Pyne, Katherine Chaplin, Daisy Gaunt, Line Guenette, Chris Salisbury

Abstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Polly DuncanCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK polly.duncan@bristol.ac.uk.ORCID 0000-0002-2244-3254
Lauren J ScottNational Institute for Health Research Applied Research Collaboration West, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.ORCID 0000-0003-3129-5123
Shoba DawsonCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0002-6700-6445
Muzrif MunasCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
Yvette PyneCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
Katherine ChaplinCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
Daisy GauntPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Line GuenetteFaculty of Pharmacy and CHU de Québec Research Center, Université Laval, Quebec city, Quebec, Canada.ORCID 0000-0001-9769-7550
Chris SalisburyCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0002-4378-3960

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo undertake further psychometric testing of the Multimorbidity Treatment Burden Questionnaire (MTBQ) and examine whether reversing the scale reduced floor effects.

designSurvey.

settingUK primary care.

participantsAdults (≥18 years) with three or more long-term conditions randomly selected from four general practices and invited by post. MEASURES: Baseline survey: sociodemographics, MTBQ (original or version with scale reversed), Treatment Burden Questionnaire (TBQ), four questions (from QQ-10) on ease of completing the questionnaires. Follow-up survey (1-4 weeks after baseline): MTBQ, TBQ and QQ-10. Anonymous data collected from electronic GP records: consultations (preceding 12 months) and long-term conditions. The proportion of missing data and distribution of responses were examined for the original and reversed versions of the MTBQ and the TBQ. Intraclass correlation coefficient (ICC) and Spearman's rank correlation (R

results244 adults completed the baseline survey (consent rate 31%, mean age 70 years) and 225 completed the follow-up survey. Reversing the scale did not reduce floor effects or data skewness. The global MTBQ scores had good test-retest reliability (ICC for agreement at baseline and follow-up 0.765, 95% CI 0.702 to 0.816). Global MTBQ score was correlated with global TBQ score (R

conclusionThis study demonstrates test-retest reliability and ease of completion of the MTBQ and builds on a previous study demonstrating good content validity, construct validity and internal consistency reliability of the questionnaire.

Indexed as

MultimorbidityAgedHumansPsychometricsRandom AllocationReproducibility of ResultsSurveys and QuestionnairesChronic DiseasePatient-Centered CarePatient Reported Outcome MeasuresPrimary CareQuality in health careSurveys and Questionnaires

Identifiers

PMID38604632
PMCPMC11015253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.